/ISCNF
ISCNF Stock - Isracann Biosciences Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ISCNF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.17
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | $1.17M |
| Gross Profit | $-41,732 | $-41,306 | $-45,128 | $-44,847 | $1.17M |
| Gross Margin | N/A | N/A | N/A | N/A | 100.0% |
| Operating Income | $-2,392,224 | $-4,777,662 | $-11,177,451 | $-5,662,816 | $-6,284,123 |
| Net Income | $-4,693,070 | $-25,155,274 | $-24,201,584 | $-9,597,688 | $-7,474,826 |
| Net Margin | N/A | N/A | N/A | N/A | -636.9% |
| EPS | $-0.03 | $-0.18 | $-0.26 | $-0.75 | $-0.33 |
Company Overview
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ISCNFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2022
EPS Surprise History
Q4 20
No data
Q1 21
No data
Q2 21
No data
Q3 21
No data
Q4 21
No data
Q2 22
No data
Q2 22
No data
Q3 22
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Oct 7, 2024 | — | — | — | — |
Q4 2024 | Oct 7, 2024 | — | — | — | — |
Q3 2022 | Aug 31, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 31, 2022 | — | $-0.01 | — | — |
Q2 2022 | Apr 27, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 30, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 31, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 31, 2021 | — | $-0.12 | — | — |
Q1 2021 | Feb 28, 2021 | — | $-0.01 | — | — |
Q4 2020 | Nov 30, 2020 | — | $-0.01 | — | — |
Q3 2020 | Aug 31, 2020 | — | $-0.00 | — | — |
Q2 2020 | May 31, 2020 | — | $-0.05 | — | — |
Q1 2020 | Feb 29, 2020 | — | $-0.03 | — | — |
Q4 2019 | Nov 30, 2019 | — | $-0.03 | — | — |
Q3 2019 | Aug 31, 2019 | — | $-0.02 | — | — |
Q2 2019 | May 31, 2019 | — | $-0.14 | — | — |
Q1 2019 | Feb 28, 2019 | — | $-0.01 | — | — |
Q4 2018 | Nov 30, 2018 | — | $-0.06 | — | — |
Q3 2018 | Aug 31, 2018 | — | $-0.11 | — | — |
Q2 2018 | May 31, 2018 | — | $-0.06 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ISCNF
What is ISCNF's current stock price?
Isracann Biosciences Inc. (ISCNF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for ISCNF?
No analyst price targets are currently available for this stock.
What sector is Isracann Biosciences Inc. in?
Isracann Biosciences Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is ISCNF's market cap?
Isracann Biosciences Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does ISCNF pay dividends?
No, Isracann Biosciences Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAVCNF
Avicanna Inc.
$0.17
Mkt Cap: $0.0B
CAAOF
INDVR Brands Inc.
$0.00
Mkt Cap: $0.0B
CHOOF
Choom Holdings Inc.
$0.00
Mkt Cap: $0.0B
CWBHF
Charlotte's Web Holdings, Inc.
$0.21
Mkt Cap: $0.0B
EVRRF
Molecule Holdings Inc.
$0.00
Mkt Cap: $0.0B
GBLP
Global Pharmatech, Inc.
$0.05
Mkt Cap: $0.0B
MEDIF
MediPharm Labs Corp.
$0.05
Mkt Cap: $0.0B
MRES
Institute of Biomedical Research Corp.
$0.00
Mkt Cap: $0.0B
RAPH
Raphael Pharmaceutical Inc.
$1.40
Mkt Cap: $0.0B
VYYRF
Voyageur Pharmaceuticals Ltd.
$0.10
Mkt Cap: $0.0B
Explore stocks similar to ISCNF for comparison